Pretreatment with magnesium sulphate is associated with less succinylcholine-induced fasciculation and subsequent tracheal intubation-induced hemodynamic changes than precurarization with vecuronium during rapid sequence induction

Acta Anaesthesiologica Belgica

Volumn 57, Issue 3, 2006, Pages 253-257

  Sakuraba, Shigeki ^a,d   Serita, R ^b   Kosugi, S ^b   Eriksson, L I ^c   Lindahl, S G E ^c   Takeda, J ^a  

^a KEIO UNIVERSITY   (Japan)

^b National Hospital Organization Kasumigaura Medical Center   (Japan)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NONE   (Japan)

Author keywords

Fasciculation; Magnesium; Rapid sequence induction; Succinylcholine; Vecuronium

Indexed keywords

MAGNESIUM SULFATE; SUXAMETHONIUM; VECURONIUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; ENDOTRACHEAL INTUBATION; FASCICULATION; FEMALE; HEART RATE VARIABILITY; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANESTHESIA, GENERAL; BLOOD PRESSURE; FASCICULATION; FEMALE; HEART RATE; HUMANS; INTUBATION, INTRATRACHEAL; MAGNESIUM; MAGNESIUM SULFATE; MALE; MIDDLE AGED; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POTASSIUM; SUCCINYLCHOLINE; VECURONIUM BROMIDE;

EID: 33749650206     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Stacey M. R. W., Barclay K., Asai T., Vaughan R. S., Effects of magnesium sulphate on suxamethonium-induced complications during rapid-sequence induction of anaesthesia, ANAESTHESIA., 50, 933-936, 1995.
2. Motsch J., Fuchs W., Hoch P., Kaas V., Hutschenreuter K., Side effects and changes in pulmonary function after fixed dose precurarization with alcuronium, pancuronium or vecuronium, BR. J. ANAESTH., 59, 1528-1532, 1987.
3. Joshi G. P., Hailey A., Cross S., Thompson-Bell G., Whitten C. C., Effects of pretreatment with cisatracurium, rocuronium, and d-tubocurarine on succinylcholine-induced fasciculations and myalgia: a comparison with placebo, J. CLIN. ANESTH., 11, 641-645, 1999.
4. Chestnutt W. N., Dundee J. W., Failure of magnesium sulphate to prevent suxamethonium induced muscle pains, ANAESTHESIA., 40, 488-490, 1985.
5. Aldrete J. A., Zahler A., Aikawa J. K., Prevention of succinylcholine-induced hyperkalaemia by magnesium sulafate, CAN. ANAESTH. SOC. J., 17, 477-484, 1970.
6. De Vore J. S., Asrani R., Magnesium sulfate prevents succinylcholine- induced fasciculations in toxemic parturients, ANESTHESIOLOGY., 52, 76-77, 1980.
7. Demers-Pelletier J., Drolet P., Girard M., Donati F., Comparison of rocuronium and d-tubocurarine for prevention of succinylcholine-induced fasciculation and myalgia, CAN. J. ANAESTH., 44, 1144-1147, 1997.
8. Harvey S. C., Roland P., Bailey M. K., Tomlin M. K., Williams A., A randomized, double-blind comparison of rocuronium, d-tubocurarine, and "mini-dose" succinylcholine for preventing succinylcholine-induced muscle fasciculations, ANESTH. ANALG., 87, 719-722, 1998.
9. Martin R., Carrier J., Pirlet M., Claprood Y., Tetrault J. P., Rocuronium is the best non-depolarizing relaxants to prevent succinylcholine fasciculations and myagenia, CAN. J. ANAESTH., 45, 521-525, 1998.
10. James M. F. M., Cork R. C., Dennette J. E., Succinylcholine pretreatment with magnesium sulphate, ANESTH. ANALG., 65, 373-376, 1986.
11. Puri G. D., Marudhachalam K. S., Chans P., Suri R. K., The effect of magnesium sulphate on hemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease, ANESTH. ANALG., 87, 808-811, 1998.
12. James M. F. M., Clinical use of magnesium infusions in anaesthesia, ANESTH. ANALG., 74, 129-136, 1992.
13. Altura B. M., Altuna B. T., Magnesium and vascular tone and reactivity, BLOOD VESSELS., 15, 5-16, 1978.
14. 2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels, CAN. J. PHYSIOL. PHARMACOL., 65, 729-745, 1987.
15. Allen R. W., James M. F. M., Uys P. C., Attenuation of the pressor response to tracheal intubation in hypertensive proteinuric pregnant patients by lignocaine, alfentanil and magnesium sulphate, BR. J. ANAESTH., 66, 216-223, 1991.
16. Viby-Mogensen J., Engbaek J., Eriksson L. I., Gramstad L., Jensen E., Jensen F. S., Koscielniak-Nielsen Z., Skovgaard L. Y., Ostergaard D., Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents, ACTA. ANAESTHESIOL. SCAND., 40, 59-74, 1996.
17. Pinchak A. C., Smith C. E., Shepard L. S., Patterson L., Waiting time after non-depolarizing relaxants alter muscle fasciculation response to succinylcholine, CAN. J. ANAESTH., 41, 206-212, 1994.
18. Jorgensen C. R., Wang K., Wang Y., Gobel F. L., Nelson R. R., Taylor H., Effects of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise, CIRCULATION, 48, 1173-1182, 1973.
19. Wilkinson P. L., Moyers J. R., Ports T., Chatterjee K., Rate-pressure product and myocardial oxygen consumption during surgery for coronary artery bypass, CIRCULATION, 60, 170-173, 1979.
20. Roy R. W., Edelist G., Gilbert B., Myocardial ischemia during non-cardiac surgical procedure in patients with coronary-artery disease, ANESTHESIOLOGY., 51, 393-397, 1979.
21. White R. E., Hartzell H. C., Magnesium ions in cardiac function: Regulators of ion channels and second messengers, BIOCHEM. PHARMACOL., 38, 859-867, 1989.
22. Agus Z. S., Morad M., Modulation of cardiac ion channels by magnesium, ANNU. REV. PHYSIOL., 53, 299-307, 1991.